| Teresa Letellier, MD | |
|
61 Barra Rd, Biddeford, ME 04005-9459 | |
| (207) 283-1441 | |
| Not Available |
| Full Name | Teresa Letellier |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 61 Barra Rd, Biddeford, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629431622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD23609 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mainehealth Care At Home | Saco, ME | Home health agency |
| Elara Caring | Kittery, ME | Home health agency |
| Hospice Of Southern Maine | Scarborough, ME | Hospice |
| Southern Maine Health Care | Biddeford, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Martin's Point Health Care | 5991776635 | 90 |
News Archive
Arena Pharmaceuticals, Inc. today reported pooled Week 52 data from more than 6,000 patients in lorcaserin's pivotal Phase 3 clinical trial program that demonstrate lorcaserin 10 mg dosed twice daily reduced body weight in all patient subgroups evaluated, as defined by gender, age, ethnicity and starting body weight and Body Mass Index (BMI). Greater improvements in cardiovascular risk factors were also achieved with lorcaserin treatment compared to placebo overall and in most subgroups.
One of the most dangerous characteristics of cancer is its ability to metastasize, or spread through the body. For this reason, oncologists have a major need for better tests to detect cells that break away from primary tumors to travel to other parts of the body.
Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive top-line results from its Phase 2a study evaluating AR-13324 for the treatment of glaucoma.
Researchers in the U.S. are suggesting that painkillers such as ibuprofen and naproxen can cut the risk of Parkinson's disease by as much as 60%.
A study using a driving simulator suggests that adolescents with attention-deficit/hyperactivity disorder (ADHD) who were distracted while driving demonstrated more variability in speed and lane position than adolescents without ADHD, according to a study published by JAMA Pediatrics, a JAMA Network publication.
› Verified 4 days ago
| Entity Name | Martin's Point Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366474611 PECOS PAC ID: 5991776635 Enrollment ID: O20040804001702 |
News Archive
Arena Pharmaceuticals, Inc. today reported pooled Week 52 data from more than 6,000 patients in lorcaserin's pivotal Phase 3 clinical trial program that demonstrate lorcaserin 10 mg dosed twice daily reduced body weight in all patient subgroups evaluated, as defined by gender, age, ethnicity and starting body weight and Body Mass Index (BMI). Greater improvements in cardiovascular risk factors were also achieved with lorcaserin treatment compared to placebo overall and in most subgroups.
One of the most dangerous characteristics of cancer is its ability to metastasize, or spread through the body. For this reason, oncologists have a major need for better tests to detect cells that break away from primary tumors to travel to other parts of the body.
Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive top-line results from its Phase 2a study evaluating AR-13324 for the treatment of glaucoma.
Researchers in the U.S. are suggesting that painkillers such as ibuprofen and naproxen can cut the risk of Parkinson's disease by as much as 60%.
A study using a driving simulator suggests that adolescents with attention-deficit/hyperactivity disorder (ADHD) who were distracted while driving demonstrated more variability in speed and lane position than adolescents without ADHD, according to a study published by JAMA Pediatrics, a JAMA Network publication.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Teresa Letellier, MD Po Box 9746, Portland, ME 04104-5040 Ph: () - | Teresa Letellier, MD 61 Barra Rd, Biddeford, ME 04005-9459 Ph: (207) 283-1441 |
News Archive
Arena Pharmaceuticals, Inc. today reported pooled Week 52 data from more than 6,000 patients in lorcaserin's pivotal Phase 3 clinical trial program that demonstrate lorcaserin 10 mg dosed twice daily reduced body weight in all patient subgroups evaluated, as defined by gender, age, ethnicity and starting body weight and Body Mass Index (BMI). Greater improvements in cardiovascular risk factors were also achieved with lorcaserin treatment compared to placebo overall and in most subgroups.
One of the most dangerous characteristics of cancer is its ability to metastasize, or spread through the body. For this reason, oncologists have a major need for better tests to detect cells that break away from primary tumors to travel to other parts of the body.
Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive top-line results from its Phase 2a study evaluating AR-13324 for the treatment of glaucoma.
Researchers in the U.S. are suggesting that painkillers such as ibuprofen and naproxen can cut the risk of Parkinson's disease by as much as 60%.
A study using a driving simulator suggests that adolescents with attention-deficit/hyperactivity disorder (ADHD) who were distracted while driving demonstrated more variability in speed and lane position than adolescents without ADHD, according to a study published by JAMA Pediatrics, a JAMA Network publication.
› Verified 4 days ago
Mr. James J Richard, NP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11 Hills Beach Rd, Biddeford, ME 04005 Phone: 207-602-2358 Fax: 207-602-5904 | |
David Strassler, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 61 Barra Road, Biddeford, ME 04005 Phone: 207-283-1441 Fax: 207-523-1136 | |
Dr. Daniel Mazza Iii, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Drive, Biddeford, ME 04005 Phone: 207-294-5050 | |
Rita K Kamra, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 208 Graham St, Biddeford, ME 04005 Phone: 076-023-5712 Fax: 207-602-3573 | |
Kathryn P Desrosiers, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 22 W Cole Rd Ste 101, Biddeford, ME 04005 Phone: 207-780-6565 Fax: 207-800-4932 | |
Dr. Christian Basque, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 46 Barra Rd Ste 103, Biddeford, ME 04005 Phone: 207-283-1126 | |
Dr. Stephen Curtis Shannon, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 11 Hills Beach Rd, Unecom, Biddeford, ME 04005 Phone: 207-283-0171 |